U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07681219) titled 'LRRK2 Parkinson's Disease Fingerprint' on June 26.
Brief Summary: The goal of this interventional monocentric study is to identify molecular and clinical markers of LRRK2-related Parkinson's disease through blood markers analysis and deep clinical phenotyping. Patients who meet the inclusion criteria, after signing the informed consent form will be clinically evaluated by a neurologist expert in movement disorders. Eventually, patients will undergo a blood sample collection, a brain MRI, and a high density EEG. All data will be collected using an ad hoc electronic Case Report Form (CRF) developed for the study
Study Start Date: Sept...